Literature DB >> 12477761

Osteoporosis in inflammatory bowel disease.

J Compston1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12477761      PMCID: PMC1773495          DOI: 10.1136/gut.52.1.63

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Pharmacological interventions for post-menopausal osteoporosis: an evidence-based approach.

Authors:  J E Compston
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

2.  New steroids for IBD: progress report.

Authors:  S B Hanauer
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

3.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis.

Authors:  P Vestergaard; K Krogh; L Rejnmark; S Laurberg; L Mosekilde
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

4.  Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease.

Authors:  K V Haderslev; L Tjellesen; H A Sorensen; M Staun
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

5.  Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy.

Authors:  S Wallach; S Cohen; D M Reid; R A Hughes; D J Hosking; R F Laan; S M Doherty; M Maricic; C Rosen; J Brown; I Barton; A A Chines
Journal:  Calcif Tissue Int       Date:  2000-10       Impact factor: 4.333

6.  The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.

Authors:  C N Bernstein; J F Blanchard; W Leslie; A Wajda; B N Yu
Journal:  Ann Intern Med       Date:  2000-11-21       Impact factor: 25.391

7.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Authors:  J D Adachi; W G Bensen; J Brown; D Hanley; A Hodsman; R Josse; D L Kendler; B Lentle; W Olszynski; L G Ste-Marie; A Tenenhouse; A A Chines
Journal:  N Engl J Med       Date:  1997-08-07       Impact factor: 91.245

  9 in total
  6 in total

1.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  M J Carter; A J Lobo; S P L Travis
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Ileum resection is the most predictive factor for osteoporosis in patients with Crohn's disease.

Authors:  R A van Hogezand; D Bänffer; A H Zwinderman; E V McCloskey; G Griffioen; N A T Hamdy
Journal:  Osteoporos Int       Date:  2006-01-04       Impact factor: 4.507

3.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

4.  Validation of a CT-derived method for osteoporosis screening in IBD patients undergoing contrast-enhanced CT enterography.

Authors:  Nicholas K Weber; Jeff L Fidler; Tony M Keaveny; Bart L Clarke; Sundeep Khosla; Joel G Fletcher; David C Lee; Darrell S Pardi; Edward V Loftus; Sunanda V Kane; John M Barlow; Naveen S Murthy; Brenda D Becker; David H Bruining
Journal:  Am J Gastroenterol       Date:  2014-01-21       Impact factor: 10.864

5.  Postprandial response of bone turnover markers in patients with Crohn's disease.

Authors:  Ioannis Karatzoglou; Maria P Yavropoulou; Maria Pikilidou; George Germanidis; Evangelos Akriviadis; Alexandra Papazisi; Michael Daniilidis; Pantelis Zebekakis; John G Yovos
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Efficacy and safety of bisphosphonates in management of low bone density in inflammatory bowel disease: A meta-analysis.

Authors:  Liwei Yao; Haiqing Wang; Wenwei Dong; Zhenxin Liu; Haijiao Mao
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.